Episodes

Nov 25, 2019
Nov 25, 2019
20 min
Drs Patrick Myers, David Taggart, and Michael Mack discuss the ORBITA trial, focusing on the importance of the sham-control design of the trial, ORBITA's context within previous and upcoming trials, and what the results mean for cardiac surgeons.
Version: 20241125

No comments yet. Be the first to say something!